chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19 positive on 5/12/2021. HPI:  This is a 72 year old female with past medical history of: #Breast Cancer  - Follow up with Dr.  - pT1cN0 triple negative, metaplastic carcinoma - invasive mammary carcinoma with chrondromyxoid matrix production - (grade 3) of the left breast, diagnosed in 1/2021. - s/p L partial mastectomy w/ sentinel node dissection in 2/2021 - started on adjuvant chemotherapy - docetaxel/cyclophosphamide (last tx - cycle 2 on 5/7) - plan is to follow w/ radiation tx #Hx of Bell's palsy, right sided facial droop  - s/p prednisone 25 mg for 10 days and 3 days of valacyclovir #HTN - on lisnopril 10 mg #HL - on lipitor 10 mg #GERD - on pantoprazole 20 mg daily #Anxiety/Depression - Buspirone 30 mg BID, 250 mg fluvoxamine, clonezapam 2.6 mg prn #Insomnia - on trazadone 100 mg qhs #Hx of Acute Labyrinthitis and hx of otitis media - on meclazine TID PRN   She was recently admitted to the hospital for neutropenic fever and noted to have COVID+. She was on room and appear to be mild COVID at that time. No Dexa or Remdisivir was given and she was discharged home to complete her 2x week quarantine.  Today, she returned to ER with shortness of breath, worsening productive cough, fatigue, decreased appetite, watery diarrhea for 2 days. Denied any trauma, headache, fever, leg swelling, blurred vision, chest pain, palpitation, hemoptysis, abdominal pain, nausea, vomiting, or any urinary symptoms. No dysarthria or focal neurological deficit. Reported adherence with medication.   COVID pneumonia - known COVID +, now presented with SOB requiring oxygen - admit to COVID 19 unit - Isolation precaution per COVID protocol - Check ferritin, ldh, procalcitonin, d dimer, pt/inr,  - Trend hs tnt - Oxygen management per unit protocol - Start Dexa + Remdisivir - ID consult in am   #Breast Cancer - follow up with Oncology team in am   #HTN - BP stable - resume home lisnopril 10 mg   #HLD - Continue lipitor 10 mg   #Hx of Bell's palsy, right sided facial droop  - Right facial droop at baseline - Completed prednisone 25 mg for 10 days and 3 days of valacyclovir   #GERD - Continue pantoprazole 20 mg daily   #Anxiety #Depression - Continue home Buspirone 30 mg BID, 200 mg fluvoxamine, clonezapam 0.25 mg prn   #Insomnia  - Continue trazadone 100 mg qhs   #Hx of Acute Labyrinthitis and hx of otitis media  - Continune meclazine TID PRN   Remdesivir 5/20-5/24 Decadron 5/21-present Tocilizumab 5/20
Information has been received from a physician concerning female patients who were vaccinated with 0.5 ml doses of Gardasil.  Subsequently the patients "got their periods" a couple of days after receiving Gardasil.  The patients contacted the physician.  At the time of the report the patients' outcomes were unknown.  Additional information has been requested.
Information has been received from a registered nurse concerning a female (age not reported) who on an unspecified date was vaccinated with Gardasil. Subsequently, the patient developed an "adverse reaction". No details were given of the adverse experience. At the time of this report, the outcome of the event was unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 1/16/2007.  Initial and follow up information has been received from a licensed practical nurse (previously reported as registered nurse) and the mother of a 15 year old female student.  On 19-OCT-2006, the patient was vaccinated in the left deltoid with the first dose of GARDASIL (Lot # 653736/0689F).  The mother reported that on 14-DEC-2006, her daughter had been ill since the shot.  The patient sought unspecified medical attention.  It was reported that the primary care physician (PCP) had advised against getting another shot.  At the time of this report, the patient had recovered from the event (date unknown).  Additional information has been requested.
Offsite clinic 9/24/22: Father and child repeatedly insisted that the child's birthdate and that he is 12 years old. On 9/27/22: Called father with supervisor present. Father has fair understanding. I asked him when his son's birthday was. He said he needed to check. He returned to phone a few minutes later and said that birthday. I explained to him tat his son was given an adult dose of vaccine because he had insisted that his birthday and that he was 12 years old. Son is ok - no adverse affects. I reminded him to give the correct birthdate next time gets a vaccine. Also, that the next COVID vaccine will be age appropriate.  I advised him to call if he had further questions or concerns. He has her number. He stated that he understood all that we discussed.
Redness, swelling at injection site shortly following office visit for vaccination; rash is growing and covers approximately a 7 in x 3 in area of (L) arm. No tenderness or burning. Suggested treatment: cold compresses, ibuprofen, BENADRYL.
Patient presented to ED o 2/13 for right knee pain post fall (pain level 10/10) starting 11/3/2020 post rehab. Right knee x-ray showed extensive osteoarthritis with periarticular calcification, intra-articular loose bodies, no fracture. Pain initially  managed with Percocet.  PT/OT recommended outpatient physical therapy and NSAIDS. Patient stable and  discharged for further rehab 2/15. Per , hospitalizations are to be reported irrespective of attribution to the vaccine. This hospitalization does not appear to be related to the vaccine.
Initial unsolicited report received from a physician on 19 December 2014. A patient whose age, gender, medical history and concomitant medications were not reported, had received TD VACCINE (dose details, batch number, route of administration and site of administration was not reported) in the year 1981. On an unspecified date after vaccination, the patient experienced fever, joint pain and local site reaction. It was stated that the patient had not received "Td product" at the reporter's facility and did not have any other information regarding what patient had received or the symptoms experienced following vaccination. Illness at time of vaccination, Pre-existing physician diagnosed allergies, birth defects and medical conditions were not reported. Laboratory investigations and corrective treatments were not provided. At the time of this report, the patient was recovered. Documents held by sender: none.
DIZZINESS, NAUSEA, BODY TINGLING, HEART RACING, HEADACHE REPORTED RIGHT AFTER INJECTION. SYMPTOMS LASTED FOR ABOUT AN HR
Head is going to explode; feel like my body has been run over; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for COVID-19 immunisation; Typhoid vaccine; Hepatitis a vaccine; Hepatitis b vaccine; Polio vaccine; Yellow fever vaccine; Japanese encephalitis vaccine; Meningitis vaccine. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Head is going to explode"; FATIGUE (non-serious), outcome "unknown", described as "feel like my body has been run over".  Additional information: The patient stated that the side effects are absolutely abysmal that no one should have to go through that.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On or about 04-APR-2014, the patient was vaccinated with a dose of ZOSTAVAX (exact dose, route of administration, anatomical localization, lot # and expiration date were not reported) for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. On an unknown date in 2014 (reported as later in 2014), the patient was treated for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles (onset on an unspecified date in approximately 2014). As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient had suffered and would continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of vaccination failure and herpes zoster was unknown. The reporter considered vaccination failure and herpes zoster to be related to ZOSTAVAX.
Patient arrived to the vaccine clinic, received both the Pfizer Bivalent vaccine and the Flucelvax Quadrivalent Influenza Vaccine.   Patient vaccinated at 0625 Patient complained of itchiness all over the arms, torso, legs, and back. Patient did not complain of swelling of the tongue, dysphagia, or trouble breathing. Medic, EMT, and RN verified symptoms and patient assessment.  0630 Assessed patient with vaccination team, no shortness of breath or swelling noted, lung sounds clear. Hive started to appear.   0635 Assessed vitals. Administer IM Benadryl, assessed patient and called medical team on site to assess patient. Hive started to dissipate.
Directly after vaccine felt like my skin was crawling and then developed a headache and muscle aches.
22 Y male with past medical history of environmental allergies presents with a chief complaint of abdominal pain and nausea/ vomiting. He states that on 4/7 he had some nausea and one episode of non bloody nonbilious emesis that morning. He had previously received his first dose of the Moderna COVID vaccine on 4/6. He states this morning he awoke and had significant nausea and abdominal pain and then had approximately 10 episodes of non bloody emesis that eventually became bilious. He did have some diaphoresis. He states that he eventually did have some chest pain that he attributed to all of the vomiting. He went to urgent care and did receive Zofran but this did not alleviate his symptoms. He denies shortness of breath, cough, fever, chills, diarrhea, melena, hematochezia, genitourinary symptoms, or other pain. He states that he has been having a few episodes of loose stools, but did not have any bowel movements today. In urgent care CT was performed and was suspicious for pneumomediastinum within the partially imaged lower chest and a CT esophagram was recommended. Patient presented here for CT esophagram. He is admitted for further treatment, and required a three day admission with IVF, and IV narcotics and antiemetics to control his nausea and Abd symptoms. He denied dyspnea. On 4/11 the patient was tolerating a diet and stable to dc home.
Pt c/o itching and site tender to touch. States really noticed it on 01/11/2021. Localized redness noted on left upper arm.
Red patch inferior to injection site at left arm. Site is warm to the touch. Declines any fever, SOB, chills. Treated for cellulitis - AUGMENTIN.
Had a temperature of 105.1f within 12 hours of second injection. Fever slowly subsided over the next 16 hours.; This is a spontaneous report from a contactable consumer (patient).  A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EW0171), via an unspecified route of administration, on 30Apr2021 03:00 PM (at the age of 38 years old) on left arm as a dose 2, single for COVI1-9 immunization. Patient medical history and concomitant medication were not reported. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EW0153), via an unspecified route of administration, on 09Apr2021 05:00 PM (at the age of 38 years old) on left arm as a dose 1, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Patient had not received any other vaccine in four weeks and patient had not received any other medications within two weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination and patient was not tested for COVID-19 since the vaccination. On 01May2021 patient had temperature of 105.1 F within 12 hours of second injection. Fever slowly subsided over the next 16 hours. Patient received the treatment of ibuprofen and acetaminophen stacking. Patient had undergone lab test and procedures which include body temperature resulted as 105.1 F on 01May2021. The outcome of the event was recovered with Sequel on unspecified date in 2021.
This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient reported he takes a blood thinner. Received 1st dose of vaccine and "look like blood when I was spitting/hacking up last night, this morning no blood." The outcome of the event was unknown.   No follow-up attempts are possible. Information on lot/batch cannot be obtained. No further information is expected.
Nausea; Headache; Arm pain; Muscle aches; This is a spontaneous report from a non-contactable consumer (patient). An 18-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Not reported), via unspecified route, in right arm on 09Jul2021 as dose 1, single for COVID-19 immunization. Patient medical history included COVID-19. Concomitant medications included meningococcal vaccine for Meningitis. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included nasal swab: results unknown on an unknown date. The patient experienced nausea, headache, arm pain and muscle aches in Jul2021. No seriousness criteria reported. No treatment was taken for the events. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Tingling in hands & feet began appx 9/22, loss of feeling bottom of feet, no strength in hands, unable to stand for very long, sensitive to air on arms, loss of balance, all symptoms increased, back spasms began appx 10/1, Bell's palsy 10/2, loss of vision in right eye.
Case number PHEH2013US021884 in an initial spontaneous report received from a consumer (health care professional) on 16 OCT 2013. This report refers to a 43-years-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUCELVAX 2013/2014 (batch number: not reported) intramuscularly on 14 OCT 2013. On the same date, she began to experience hives and flushing on her face and neck. Her vaccination site about the size of a 3x5 inch card became swollen,  hot, red and very painful. The outcome of the events was reported as condition unchanged. No further information was provided.
Reports of having symptoms of severe bilateral leg pain at night. Started Sunday 4/11/21 at 11:00 pm and reports pain was so severe it kept her awake for 4-5 hours on night of 4/11-4/12 and had the same leg cramps 4/12 night and 4/13 night, noting the last two episodes did not last as long. Currently report of having swelling to left knee, tenderness to bilateral knees and bilateral calves.
feet ankle and legs are very swollen. patient states foot is too swollen to war a show.
Prolonged muscle soreness at injection site. From stabbing pain to ache. Not as painful as the first 2 mos after shot. Now periodic soreness at site. Aches.
New onset seizure day of vaccination. Apnea, hypotonia with post-ictal state. Seizure activity lasting up to 2 minutes; multiple episodes over next several days.
Woke up morning after at 5 am with extreme fatigue, and muscle pain at injection site. About a half hour later had diarrhea and developed nausea. All symptoms continued throughout the day, until the nausea and diarrhea stopped at about 6 pm. Fatigue and pain at injection site continued, and approximately 8pm developed muscle pain in legs. Specifically calves. Symptoms continued and I  went to sleep.  Next day fatigue and injection site pain continues but isn?t as bad
Headache, Myalgia, Arthralgia, Diarrhea, Chills Narrative:  Received 2nd dose on 1/20/21. Four hours after injection noted severe headache, diarrhea, myalgias, arthralgias, and chills. Headache lasted 4 days, other symptoms improved within 24 hours. Missed one day of work. No known prior COVID infection.  Other Relevant History:
All on the same day - or the head happened the day before - I can't really remember which:  I tripped on something and hit the right side of where my hairline is, above my eyebrow on my head and had a 3 inches bruise. I put ice on and that swelled. ( Before my fall, I had indigestion and gastritis. I was told I had gastritis in May 2021.) After my pain, I had pain in my torso, and that became severe and I had to stop what I was doing - like my whole body was in pain. Pressure on my chest and a lot of pressure also on my back. Kind of symptoms like  a heart attack but I knew it wasn't a heart attack .It felt like it was all over my body but mostly in my torso - but I couldn't know exactly where I was pain.  It wasn't in my feet or my hands. On Thursday night, I had a fever of 101.9 at night and the next night I had 101. 8. I went to Urgent Care because it was Saturday (I had called my doctor on Friday but didn't get a callback.) They ran a lot of tests. Prescribed a med to take after diagnosing me with duodenitis - it did help with my symptoms. I have severe heartburn after I came off that medication I got at the Carafate. I still experience indigestion too and I'm medication for that now - (from my regular doctor) - Famotidine. I did stop having the body pain.  I went to Urgent Care 3 times to them.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/20/2022 HTN (HYPERTENSION) J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/20/2022 NEUTROPENIC FEVER, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/20/2022 ADULT T-CELL LEUKEMIA W LYMPHOMA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/20/2022 NEUTROPENIC FEVER, UNSPECIFIED
Initial misuse report received from a healthcare professional on 30 December 2013. The cases were received on 21 March 2014. It was reported that 45-year-old patient had received FLUZONE HD vaccine inadvertently. No adverse event was reported. List of documents held by sender: none.
Pain between my shoulder and elbow that is moving down my arm to the top of my hand; A spontaneous report  was received from a consumer concerning herself, a 82-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event pain between my shoulder and elbow that is moving down my arm to the top of my hand.  The patient's medical history was not provided. Concomitant medications reported were digoxin, simvastatin, warfarin, alendronic, vitamin B12, ascorbic acid tocopheryl acetate xantophyl zeaxanthin zinc and triamterene.  The patient received their first of two planned doses of mRNA-1273 (Batch number: 030L20A) on 20 Jan 2021.  On 23 Feb 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 024M20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 25 Feb 2021, two days after receiving mRNA-1273, the patient experienced  pain between her shoulder and elbow that was moving down her arm to the top of her hand. Treatment given for the event included ibuprofen and diclofenac.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable  The outcome of event, pain between my shoulder and elbow that is moving down my arm to the top of my hand was unknown.
This spontaneous report was received from a male pharmacist of unknown age referring to himself. The patient's pertinent medical history, drug reactions/allergies and concomitant therapies were not reported. On an unspecified date, the patient received first injection of VARIVAX (lot#, expiry date and dosing details unknown). The patient was tested for VARIVAX "Immunoglobulin M (IGM) titers" on an unspecified date by an unspecified medical facility that reported "the levels were low" (no specifics given). The patient reported that he received a second injection of VARIVAX (lot#, expiry date and dosing details unknown) on an unknown date and was tested again for VARIVAX "Immunoglobulin M (IGM) titers" on an unknown date and reported the "the levels were again low". The outcome of antibody test negative was unknown. Causality assessment was not provided. There was no product quality complaint (PQC) involved. Additional information is not expected as the reporter denied consent to be contacted for further information.
have a round sore spot that is huge around were I got my shot; sore spot that is huge around were I got my shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (have a round sore spot that is huge around were I got my shot) and VACCINATION SITE PAIN (sore spot that is huge around were I got my shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (have a round sore spot that is huge around were I got my shot) and VACCINATION SITE PAIN (sore spot that is huge around were I got my shot). At the time of the report, VACCINATION SITE REACTION (have a round sore spot that is huge around were I got my shot) and VACCINATION SITE PAIN (sore spot that is huge around were I got my shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's medical history was not provided.  patients lab tests data not provided. Concomitant product use was not provided. Treatment information was not provided.
After the injection at 3:47, my arm begin to get sore and sorer. By 7 pm, my arm was really aching to the point of not touching it and carrying it as if it was in a sling. By 10:00 pm, approximately 6 hours after the injection, I begin to have the intense shivers lasting approximately 6 hours, with fever of 101.9 to 102.3, followed by an extreme headache in the front top of my head which later at 10:30 pm shifted to the left lobe of my head and continued until 5:30 am on Friday, August 3, 2018. Nausea is an understatement. I was so sick at my stomach I wanted to throw up but couldn't to get relief. My stomach was sore and on fire. The nausea lasted from 3:00 am on August 2nd until around 8:00 pm. At 10:00 pm, I managed to get some broth and crackers down. I continued to drink ginger ale, water, and Pedalite. My joints and muscles ached. On Friday, August 3rd, I am experiencing fatigue and light headedness.
pt recv vax & 3 days later pt rash, bronchial asthma,wheezing, SOB, arthralgia, pain in large joints, rhinitis, congestion, hypertension; pruritic rash, resp distress, cough, polyarthritis